(Q52000587)

19 April 2018

title

Prevalence and severity of cognitive impairment with and without dementia in an elderly population. (English)

1 reference

19 April 2018

main subject

dementia

0 references

cognitive dysfunction

1 reference

2

K Rockwood

1 reference

19 April 2018

author name string

J E Graham

1

1 reference

19 April 2018

B L Beattie

3

1 reference

19 April 2018

R Eastwood

4

1 reference

19 April 2018

S Gauthier

5

1 reference

19 April 2018

H Tuokko

6

1 reference

19 April 2018

I McDowell

7

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 June 1997

1 reference

19 April 2018

published in

The Lancet

1 reference

19 April 2018

volume

349

1 reference

19 April 2018

page(s)

1793-1796

1 reference

19 April 2018

issue

9068

1 reference

19 April 2018

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

15-year longitudinal study of blood pressure and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

Is there a role for estrogen replacement therapy in the prevention and treatment of dementia?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

Protective effect of chronic NSAID use on cognitive decline in older persons.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

Progression to dementia in patients with isolated memory loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

A New Systematic Method of Measurement and Diagnosis of “Mild Cognitive Impairment” and Dementia According to ICD-10 and DSM-III-R Criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

Prevalence of Alzheimer's disease in a retirement community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

Subclinical dementia: relevance of cognitive symptoms and signs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

A two-year longitudinal study of cognitive function in normal aging and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2901007-6

7 January 2021

10.1016/S0140-6736(97)01007-6

Identifiers

DOI

1 reference

19 April 2018

PubMed ID

9269213

1 reference

19 April 2018